The first Ginkgo Bioworks Holdings trade was made in Q3 2021.
Since then Baillie Gifford bought shares four more times and sold shares on eight occasions. The investor completely sold their stake between Q1 2023 and Q3 2024.
Avg closing price
Price range
Sold -3.36 Million shares
Q3 2024
Avg closing price
$9.97
Price range
$5.36
-
$15.20
Sold 42.3% shares (-2.46 Million shares)
Q2 2024
Avg closing price
$0.75
Price range
$0.28
-
$1.16
Sold 1.4% shares (-82.3 Thousand shares)
Q1 2024
Avg closing price
$1.29
Price range
$1.06
-
$1.67
Sold 1.1% shares (-62.9 Thousand shares)
Q4 2023
Avg closing price
$1.53
Price range
$1.26
-
$1.79
Sold 0.9% shares (-56.8 Thousand shares)
Q3 2023
Avg closing price
$2.00
Price range
$1.61
-
$2.54
Sold 0.7% shares (-44.7 Thousand shares)
Q2 2023
Avg closing price
$1.48
Price range
$1.14
-
$1.95
Sold 0.5% shares (-32.7 Thousand shares)
Q1 2023
Avg closing price
$1.58
Price range
$1.20
-
$2.19
Increased shares by 19.6% (+1 Million shares)
Q4 2022
Avg closing price
$2.30
Price range
$1.63
-
$3.52
Sold 0.6% shares (-31.3 Thousand shares)
Q3 2022
Avg closing price
$2.98
Price range
$2.38
-
$3.74
Increased shares by 22.4% (+939 Thousand shares)
Q2 2022
Avg closing price
$3.05
Price range
$2.20
-
$4.20
Increased shares by 53.3% (+1.46 Million shares)
Q1 2022
Avg closing price
$4.87
Price range
$2.83
-
$8.69
Increased shares by 20.3% (+461 Thousand shares)
Q4 2021